Pharmac to fund two oestrogen patches
Patients will be able to use either brand, "subject to availability".
Photo:
123RF
People who need oestrogen patches will have access to two brands free of charge from 1 December.
Pharmac announced they had decided following consultation earlier this year to fund the oestradiol patches Estradot and Estradiol TDP Mylan.
Patients will be able to use either brand, "subject to availability".
Manager for pharmaceutical funding Adrienne Martin said the agency understood the importance for "people to have access to the treatment that works best for them".
"We've heard very clearly from many people that while different brands of patches should work the same, this is not everyone's experience.
"That's why we're funding two brands - so that people can access the oestradiol patches they need, depending on availability."
From 1 December, the other currently funded brands of oestradiol patches will no longer be funded.
The final decision followed a public backlash to Pharmac's
decision in November
to fund only the Mylan-brand, due to ongoing shortages of Estradot.
More than 1300 people signed a petition calling on the government to keep the Estradot brand available on the basis the Mylan-brand was less effective in controlling menopausal symptoms.
Martin said more than 1100 people responded to Pharmac's request for public feedback earlier this year.
"We heard from people who wanted us to remove the patch limit and change the dispensing rules," said Martin.
"We acknowledge how frustrating these limits are for people but changing or removing them would put pressure on demand, which would increase the risk of these patches not being available.
"We will review the patch limit and dispensing rules in 12 months depending on the supply outlook."
Pharmac would continue to monitor supply and work to ensure people can access the treatments they need, she said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
10 hours ago
- RNZ News
Youth offending drops with safe, stable housing
Photo: RNZ / Nate McKinnon An Otago University study has found a link between safe, stable housing and a reduction in youth offending rates. The study looked at the relationship between different types of housing assistance, including emergency housing, public housing, and the accommodation supplement. Lead author Chang Yu said researchers found clear links between housing deprivation and alleged youth offending. "We found offending decreased significantly among young people living in public housing or receiving the accommodation supplement, compared with the general population. "The research underscores the importance of stability in housing assistance - more stable forms of assistance are associated with better outcomes beyond shelter, particularly in reducing youth justice involvement. "Emergency housing - which provides accommodation for seven nights - remains a highly debated model, attracting both support and criticism. This study adds to the debate by showing that emergency housing does not appear to reduce youth offending." The study found that 3 years after moving into public housing, alleged offences and court charges among young people reduced by 11.7 percent and 10.9 percent more than the general population. Rates of alleged offending and court charges also decreased by 13 percent among those receiving an accommodation supplement. Yu said stable and longer-term housing can positively impact whānau and provide social cohesion. "If you have stable housing, then the kids can consistently attend school and develop community bonds. The parents will have more time to spend with their children." he said. It found Māori and Pacific youth face systemic disadvantages in both the housing and justice systems. "Housing deprivation is closely linked to justice sector involvement. This suggests that youth offending cannot be addressed in isolation from housing conditions - addressing structural inequities in housing is essential for meaningful justice reform." Yu called for the government to move beyond short-term solutions for housing that provided more security for people to survive. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
13 hours ago
- RNZ News
Approaching life-changing diagnosis for "missing millions" with ME/CFS
Photo: Professor Warren Tate Photo: Supplied Anyone who has or knows someone with ME, chronic syndrome fatigue or long covid knows that being believed is one of the toughest parts of having the condition. University of Otago Emeritus Professor Warren Tate has dedicated his life to researching ME/CFS and is considered a leading authority on long covid. Along with his team, he has been developing a diagnostic test, that so far has shown promising results. If implemented, it would be life-changing. Warren and his co-researcher Dr Katie Peppercorn have also released a one-of-a-kind book to help clinicians and researchers find ways of better understanding post-viral conditions and improve the lives of those 'missing millions' affected with ME/CFS and most recently long covid.
RNZ News
13 hours ago
- RNZ News
Approaching life-changing diagnosis for 'missing millions'
Photo: Professor Warren Tate Photo: Supplied Anyone who has or knows someone with ME, chronic syndrome fatigue or long covid knows that being believed is one of the toughest parts of having the condition. University of Otago Emeritus Professor Warren Tate has dedicated his life to researching ME/CFS and is considered a leading authority on long covid. Along with his team, he has been developing a diagnostic test, that so far has shown promising results. If implemented, it would be life-changing. Warren and his co-researcher Dr Katie Peppercorn have also released a one-of-a-kind book to help clinicians and researchers find ways of better understanding post-viral conditions and improve the lives of those 'missing millions' affected with ME/CFS and most recently long covid.
